A long-acting medicine developed by Novo Nordisk has been recommended as a treatment option for young people with growth ...

IntegriMedical has introduced a needle-free injection system (N-FIS) that eliminates the need for any prick or piercing, ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for TransCon ® CNP (navepegritide) for the treatment of children with achondroplasia, a rare ...

DataM Intelligence | competitive Intelligence Achondroplasia drug market sees rising competition, with weekly and oral treatments targeting ...

Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...

NICE is also looking at the role of Hympavzi in treating severe haemophilia A, where there are other subcutaneous options ...

(Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced ...

FOX: I am writing to ask you for help. As you know, our pets are in an overpopulation crisis. I have been networking with others across California, and in other states, to try and rescue dogs before ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

It’s also approved for children ages 12 to 17 with a body ... ultra-fine NovoFine disposable needles to deliver subcutaneous injections. These needles have an extremely fine 32-gauge tip to ...

Allergy sufferers in Malta might soon breathe a little easier. A local leader in healthcare distribution has just launched ...